- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Download Graphics from the Report:
Page 2: A Three-Part Agenda for Ending AIDS: 2015 Page 3: AVAC Report 2014/15 At a Glance Page 4: A Target That Worked: "3 by 5" Page 5: Anatomy of a Target Page 6: Watch this Space: New trials and data on the horizon Page 7: Watch this Space: Targets, action plans and budgets Page 8: Mind the Gap Page 9: New Infections in Low- and Middle-Income Countries by Scenario Page 11: Targets that Worked: VMMC and ART Page 11: Targets that Require Work: PrEP and Combination Prevention Page 12: Past Success, Present Gaps: VMMC targets, 2011 and today Page 13: Watch this Space: ARV-based prevention Page 14: Global ART Coverage (2014) Page 15: Language Watch: Defining key populations Page 17: Change in Funding for Civil Society Organizations for Human Rights-Related Work Page 19: More Positive PrEP Data in 2014 Page 20: From Proof-of-Concept to Prevention Phenomenon in Five Years Page 21: Planned, Ongoing and Completed PrEP Evaluation Studies Page 22: What to Expect for PrEP in Africa in 2015 Page 24: Decoding Complex Science: Deepening stakeholder engagement Page 27: Global HIV Prevention R&D Investment (2009-2013) Page 28: What's Next for the Pox-Protein Public-Private Partnership (P5)? Page 29: What Do Advocates Need to Know about the P5 and Why Should They Care? Page 31: A Call to Action in Vancouver 2015 and Durban 2016 Page 32: About AVAC